294
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Compliance with oral antibiotic regimens and associated factors in Japan: Compliance survey of multiple oral antibiotics (COSMOS)

, , , , , , , , , & show all
Pages 93-99 | Received 06 Feb 2011, Accepted 25 Aug 2011, Published online: 22 Oct 2011

References

  • Green JL, Ray SP, Charney E. Recurrence rate of streptococcal pharyngitis related to oral penicillin. J Pediatr 1969;75: 292–4.
  • Jordan WC. Doxycycline vs. tetracycline in the treatment of men with gonorrhea: the compliance factor. Sex Transm Dis 1981;8:105–9.
  • Alger LS, Lovchik JC. Comparative efficacy of clindamycin versus erythromycin in eradication of antenatal Chlamydia trachomatis. Am J Obstet Gynecol 1981;165:375–81.
  • Anastasio GD, Little JM Jr, Robinson MD, Pettice YL, Leitch BB, Norton UJ. Impact of compliance and side effects on the clinical outcome of patients treated with oral erythromycin. Pharmacotherapy 1994;14:229–34.
  • Cheung R, Sullens CM, Seal D, Dickins J, Nicholson PW, Deshmukh AA, . The paradox of using a 7-day antibacterial course to treat urinary tract infections in the community. Br J Clin Pharmacol 1988;26:391–8.
  • Venuta A, Laudizi L, Beverelli A, Bettelli F, Milioli S, Garetti E. Azithromycin compared with clarithromycin for the treatment of streptococcal pharyngitis in children. J Int Med Res 1988;26:152–8.
  • Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial. Lancet 2002;360:835–41 [Erratum: Lancet 2003;361:788.].
  • Agarwal G, Awasthi S, Kabra SK, Kaul A, Singhi S, >Walter SD; ISCAP Study Group. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial. BMJ 2004;328:791.
  • Pechere JC. Patient's interviews and misuse of antibiotics. Clin Infect Dis 2001;33(Suppl 3):S170–3.
  • Thomas JK, Forrest A, Bhavnani SM, Hyatt JM, Cheng A, Ballow CH, . Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob Agents Chemother 1998;42:521–7.
  • Miravitlles M, Murio C, Guerrero T, Gisbert R; for the DAFNE Study Group. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 2002;121:1449–55.
  • Kardas P, Devine S, Golembesky A, Roberts C. A systematic review and meta-analysis of misuse of antibiotic therapies in the community. Int J Antimicrob Agents 2005;26:106–13.
  • Kardas P. Patient compliance with antibiotic treatment for respiratory tract infections. J Antimicrob Chemother 2002;49:897–903.
  • Pechere JC, Hughes D, Kardas P, Cornaglia G. Non-compliance with antibiotic therapy for acute community infections: a global survey. Int J Antimicrob Agents 2007;29:245–53.
  • Matsushima D, Okayama M, Matsushima E, Ohno S, Kajii E. Relation between the actual and ideal consultation time in the outpatient setting. Jpn J Prim Care 2004;27:179–85.
  • Tomiki Y, Kanai Y, Danbara T, Tanaka Y, Itoh S, Sato K, . Survey of outpatient waiting time. Juntendoigaku 2003; 49:102–7.
  • The Otological Society of Japan, the Japan Society for Pediatric ORL, and the Japan Society for Infectious Diseases in Otolaryngology. Guidelines for diagnosis and treatment of pediatric acute otitis media [in Japanese]. 2009 ed. Tokyo, Japan: Kanehara & Co., Ltd; 2009.
  • Yamamoto N, Aida Y, Kobayashi Y, Eguchi Y, Fujiwara Y, Oshimi H, . Parents’ concerns about taking medicine by their infants – especially antimicrobials. Niigata-ken Kouseiren Medical Journal 2006;15:13–7.
  • The Committee for the Japanese Respiratory Society Guidelines in Management of Respiratory Infections. The Japanese Respiratory Society guidelines for the management of respiratory tract infection [in Japanese]. Tokyo, Japan: The Japanese Respiratory Society; 2003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.